Study guide
3.2 Phlebotomy Order of Draw, Additives & Specimen Tube Handling
Certified Medical Assistant — CMA AAMA
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Clinical Workflow, Patient Intake & Physical Measurements
1.1 Patient Intake, Health History & Chief Complaint 1.2 Vital Signs: Temperature, Pulse, Respiration & Blood Pressure 1.3 Anthropometric Measurements, Pediatric Growth Charts & BMI 1.4 Patient Screenings & Wellness Assessments 1.5 Processing Provider Orders: Patient Instruction, Assistive Devices & Home Monitoring
2 Chapter 2: Infection Control, Asepsis & OSHA Standards
2.1 Chain of Infection & Standard vs Transmission-Based Precautions 2.2 Medical & Surgical Asepsis, Hand Hygiene & PPE Protocol 2.3 Sterilization, Autoclave Operation & OSHA Bloodborne Pathogens 2.4 Body Mechanics, Ergonomics & Risk Management
3 Chapter 3: Phlebotomy & Specimen Collection
3.1 Venipuncture Equipment, Site Selection & Safety 3.2 Phlebotomy Order of Draw, Additives & Specimen Tube Handling 3.3 Capillary Puncture, Complications & Chain of Custody
4 Chapter 4: Diagnostic Laboratory Testing & CLIA-Waived Tests
4.1 CLIA Regulations, Quality Control & Lab Safety 4.2 Urinalysis: Physical, Chemical & Microscopic Examination 4.3 Microbiological Specimen Collection & Point-of-Care Testing 4.4 Hematology: CBC, Hematocrit, ESR & Coagulation Testing 4.5 Clinical Chemistry, Metabolic Panels & Reference Ranges
5 Chapter 5: Electrocardiography & Pulmonary Function Testing
5.1 12-Lead ECG Electrode Placement & Cardiac Conduction 5.2 ECG Rhythm Identification & Artifact Troubleshooting 5.3 Pulmonary Function Testing & Peak Flow Measurement 5.4 Allergy Testing & Diagnostic Imaging Modalities
6 Chapter 6: Assisting with General & Specialty Physical Examinations
6.1 Patient Positioning, Draping & Examination Methods 6.2 Assisting with Gynecological, Obstetrical & Pediatric Exams 6.3 Sensory Examinations: Vision (Snellen/Ishihara) & Hearing (Audiometry)
7 Chapter 7: Minor Office Surgery & Wound Care
7.1 Surgical Instruments, Tray Setup & Sterile Field Maintenance 7.2 Assisting Minor Surgical Procedures & Suture/Staple Removal 7.3 Wound Cleansing, Dressing Application & Bandaging Techniques 7.4 Eye and Ear Irrigation, Cast Care, Splints & Slings
8 Chapter 8: Pharmacology Principles & Drug Classifications
8.1 Principles of Pharmacology, Pharmacokinetics & Schedules 8.2 Major Drug Classifications & Therapeutic Actions 8.3 Medication Safety, Seven Rights & Preventing Medication Errors
9 Chapter 9: Dosage Calculations & Prescription Interpretation
9.1 Metric, Household Conversions & Prescription Abbreviations 9.2 Oral, Parenteral & Reconstitution Dosage Calculations 9.3 Pediatric Dosing & Body Surface Area Calculations
10 Chapter 10: Medication Administration & Immunizations
10.1 Non-Parenteral Medication Routes (Oral, Topical, Inhalation, Instillation) 10.2 Parenteral Injections: Intradermal, Subcutaneous & Intramuscular (Z-Track) 10.3 Vaccine Administration, Schedules & Cold Chain Storage
11 Chapter 11: Emergency Preparedness, First Aid & Resuscitation
11.1 Office Emergency Triage, CPR/AED & Shock Management 11.2 Medical Emergencies: Anaphylaxis, Diabetic Crises, Seizures & Trauma
12 Chapter 12: Appointment Scheduling & Medical Reception
12.1 Scheduling Systems & Appointment Booking Methods 12.2 Matrix Setup, Cancellations, No-Shows & Triage Scheduling 12.3 Patient Reception, Registration & Intake Documentation 12.4 Urgency Triage, Resource Coordination & Ancillary Service Scheduling
13 Chapter 13: Health Information Management & Medical Records
13.1 Medical Record Types, EMR/EHR Systems & Documentation Rules 13.2 Filing Systems, ARMA Indexing Rules & Record Organization 13.3 Record Retention, Storage, Archiving & Disposal 13.4 Organizing the EHR: Patient Portal, Report Types & Pre-Visit Planning
14 Chapter 14: Health Insurance Programs & Managed Care
14.1 Commercial Insurance & Managed Care Models (HMO, PPO, POS, EPO) 14.2 Government Programs: Medicare, Medicaid, TRICARE & Workers' Comp 14.3 Insurance Verification, Referrals, Pre-Authorization & COB
15 Chapter 15: Medical Coding, Billing & Financial Practices
15.1 Diagnostic (ICD-10-CM) & Procedural (CPT/HCPCS) Coding 15.2 CMS-1500 Claim Lifecycle, Superbills & Accounts Receivable 15.3 Patient Account Bookkeeping: Day Sheets, Posting & Reconciliation
16 Chapter 16: Medical Law & Healthcare Ethics
16.1 Medical Practice Acts, CMA Scope of Practice & Licensure 16.2 Torts, Medical Negligence (4 Ds) & Malpractice Liability 16.3 Consent: Expressed, Implied, Informed & Refusal (AMA) 16.4 Healthcare Ethics, Advance Directives & Patient Rights
17 Chapter 17: HIPAA Privacy, Security & Mandatory Reporting
17.1 HIPAA Privacy Rule, Protected Health Information (PHI) & Minimum Necessary 17.2 HIPAA Security Rule, Electronic Safeguards & Breach Notification 17.3 Mandatory Reporting: Abuse, Public Health & Communicable Diseases
18 Chapter 18: Professional Communication, Psychology & Anatomy Foundations
18.1 The Communication Cycle, Verbal/Nonverbal Cues & Active Listening 18.2 Overcoming Communication Barriers & Handling Difficult Situations 18.3 Patient Education, Health Coaching & Disease Prevention 18.4 Anatomical Terminology, Body Organization & Organ Systems Overview 18.5 Health Care Team Roles, Patient Navigation & Medical Specialties 18.6 Professional Telephone Etiquette, Message Protocols & Screening 18.7 Cultural Competence, Bias, Learning Styles & Health Literacy
19 Chapter 19: Nutrition & Dietary Counseling
19.1 Macronutrients, Micronutrients, Fiber, Fluids & Supplements 19.2 Therapeutic Diets, Food Labels, Intolerances & Eating Disorders
20 Chapter 20: Anatomy, Physiology & Pathophysiology by Body System
20.1 Human Growth, Development & Lifespan Milestones 20.2 Integumentary, Musculoskeletal, Nervous & Sensory Systems 20.3 Cardiovascular, Hematologic, Lymphatic & Respiratory Systems 20.4 Digestive, Urinary, Reproductive & Endocrine Systems
3.2 Phlebotomy Order of Draw, Additives & Specimen Tube Handling
Key Takeaways Explain This Topic AI
The CLSI Order of Draw prevents cross-contamination of chemical additives between evacuated tubes, which can severely alter diagnostic test results (such as EDTA causing false hyperkalemia and hypocalcemia).
The standard CLSI sequence is: 1. Blood Cultures (Yellow/SPS), 2. Light Blue (Sodium Citrate), 3. Red/Gold/Tiger (Serum/SST), 4. Green/Light Green (Heparin/PST), 5. Lavender/Pink (K2-EDTA), 6. Gray (Sodium Fluoride/Potassium Oxalate).
Light blue sodium citrate tubes require an exact 9:1 blood-to-anticoagulant ratio and must be filled within ±10% of the manufacturer fill line to ensure accurate coagulation timing.
Serum Separator Tubes (SST) must stand upright for 30–60 minutes to complete clot formation before centrifugation; SST tubes must never be re-centrifuged.
Light-sensitive analytes (bilirubin, vitamin B12, folate) require amber containers or aluminum foil wrapping, while cold specimens (ammonia, lactic acid, blood gases) must be immediately immersed in a crushed ice and water slurry.
Last updated: August 2026
3.2 Phlebotomy Order of Draw, Additives & Specimen Tube Handling
In diagnostic phlebotomy, adhering to the standardized Clinical and Laboratory Standards Institute (CLSI) Order of Draw is non-negotiable. Modern evacuated collection tubes contain diverse chemical additives—including anticoagulants, clot activators, glycolytic inhibitors, and separator gels—designed to prepare blood for specific analytical methodologies. When multiple tubes are drawn from a single venipuncture, the needle piercing the rubber stoppers can carry micro-droplets of additive from one tube into subsequent tubes. Strict compliance with the CLSI order of draw prevents additive cross-contamination and preserves specimen integrity.
1. Rationale for the CLSI Order of Draw & Additive Cross-Contamination
The fundamental rationale behind the order of draw is preventing carryover of anticoagulants or clot activators into tubes where those substances would invalidate analytical assays. Consider these high-impact examples of additive contamination:
EDTA Carryover into Chemistry/Electrolyte Tubes: Lavender top tubes contain dipotassium EDTA (K2-EDTA). If a lavender tube is drawn before a green (heparin) or gold (SST serum) chemistry tube, trace amounts of potassium EDTA transferred by the needle will cause falsely catastrophic hyperkalemia (potassium levels exceeding 7.0 mEq/L) and falsely lethal hypocalcemia (because EDTA chelates/binds calcium, driving measured serum calcium down to <5.0 mg/dL). This artifactual finding can lead to inappropriate clinical interventions for a non-existent life-threatening cardiac emergency.
Heparin Carryover into Coagulation Tubes: Heparin inhibits thrombin and factor Xa. If drawn before a sodium citrate tube, heparin carryover artificially prolongs prothrombin time (PT/INR) and partial thromboplastin time (aPTT).
Silica Clot Activator Carryover into Coagulation Tubes: Silica particles from SST tubes carry into blue top tubes, initiating premature in vitro fibrin generation and falsely shortening coagulation times.
2. Complete CLSI Tube Sequence, Additives, Mechanisms & Common Tests CLSI Evacuated Tube Sequence & Inversion Guide
- ==============================================
- 1. YELLOW / BOTTLES --> Blood Cultures (SPS) [8-10 Inversions]
- 2. LIGHT BLUE --> Sodium Citrate (3.2%) [ 3-4 Inversions]
- 3. RED / GOLD / SST --> Clot Activator +/- Gel [ 5 Inversions]
- 4. GREEN / PST --> Lithium / Sodium Heparin [ 8-10 Inversions]
- 5. LAVENDER / PINK --> K2-EDTA [ 8-10 Inversions]
- 6. GRAY --> Sodium Fluoride / K-Oxalate [ 8-10 Inversions]
- 1. Yellow Top / Blood Culture Bottles (Microbiology)
Additive: Sodium Polyanethol Sulfonate (SPS) in yellow glass tubes, or specialized nutrient broth in blood culture bottles (Aerobic and Anaerobic).
Mechanism of Action: SPS is an anticoagulant that prevents clotting by binding calcium, but its vital clinical purpose is inhibiting phagocytosis, neutralizing bactericidal properties of human serum, and inactivating aminoglycoside/polypeptide antibiotics , allowing bacteria to proliferate for diagnostic detection.
Collection Priority: Blood cultures are always collected first to prevent dermal or airborne bacterial contamination from non-sterile tube stoppers during multi-tube draws.
Inversion Count: 8 to 10 gentle inversions.
Common Tests: Blood cultures for suspected septicemia, bacteremia, endocarditis, and fever of unknown origin (FUO).
2. Light Blue Top (Coagulation)
Additive: Buffered Sodium Citrate (3.2% or 0.109 M) .
Mechanism of Action: Anticoagulant that prevents blood from clotting by binding ionized calcium in a soluble complex. Unlike EDTA, citrate binding is reversible upon the laboratory's addition of calcium during coagulation assays.
Critical 9:1 Blood-to-Anticoagulant Ratio: The tube contains an exact volume of liquid sodium citrate calibrated to achieve a 9:1 ratio of whole blood to anticoagulant (9 parts blood to 1 part citrate). The tube MUST be filled within ±10% of the indicator fill line (90% to 100% full). An underfilled tube contains excess liquid citrate, which binds the analytical calcium reagents in the lab and causes falsely prolonged clotting times (falsely high PT/INR and aPTT). Conversely, an overfilled tube lacks sufficient citrate, allowing micro-clots to form.
Inversion Count: 3 to 4 gentle inversions . (Avoid vigorous shaking, which activates platelets and releases tissue factor, altering coagulation timing).
Common Tests: Prothrombin Time / International Normalized Ratio (PT/INR for Warfarin monitoring), Activated Partial Thromboplastin Time (aPTT for Heparin monitoring), Fibrinogen, D-Dimer (evaluating DVT/PE/DIC), and Factor Assays.
3. Red Top / Gold Top / Tiger Top (Serum Separator Tubes - SST)
Tubes & Additives:
Plain Red Glass: No additive (relies on glass contact activation for clotting).
Plastic Red Top: Contains microscopic silica clot-activator particles coated on interior tube walls.
Gold Top / Tiger Top (Red-Gray Speckled SST): Contains silica clot activator plus an inert thixotropic polyester polymer gel barrier at the bottom.
Mechanism of Action: Silica particles accelerate the intrinsic clotting cascade, promoting rapid conversion of prothrombin to thrombin and fibrinogen to fibrin clot. During centrifugation, the thixotropic gel softens and migrates to the exact interface between the heavy packed cells (RBCs/clot) and the lighter liquid serum (density ~1.04 g/mL), forming a permanent physical barrier that prevents cellular metabolism from altering serum components.
Clotting Time Requirement: Blood must stand undisturbed at room temperature for 30 to 60 minutes to achieve complete fibrin retraction before centrifugation. Centrifuging un-clotted blood produces gelatinous fibrin strands that clog automated analyzer probes.
Inversion Count: 5 inversions for plastic red and gold SST (0 inversions for plain red glass).
Common Tests: Comprehensive Metabolic Panel (CMP), Basic Metabolic Panel (BMP), Lipid Profile, Hepatic Function Panel, Renal Function Panel, Thyroid Panel (TSH, Free T4), Cardiac Biomarkers (Total CK, Troponin), Serology/Immunology (HIV, Hepatitis, RPR), and Therapeutic Drug Monitoring (TDM—note: plain red glass is preferred for certain lipophilic drugs like phenytoin or tricyclic antidepressants that may adsorb into polymer gel).
4. Green Top / Light Green Top (Plasma Separator Tubes - PST)
Tubes & Additives:
Dark Green: Sodium Heparin, Lithium Heparin, or Ammonium Heparin.
Light Green / Mint (PST): Lithium Heparin plus a thixotropic polymer gel barrier.
Mechanism of Action: Heparin accelerates the activity of Antithrombin III , which rapidly neutralizes thrombin (Factor IIa) and Factor Xa, completely preventing the conversion of fibrinogen to fibrin.
Clinical Advantage: Heparin produces plasma without requiring the 30–60 minute clotting delay of serum tubes. This makes green top tubes the universal standard for STAT chemistry testing .
Cation Specificity: Lithium heparin cannot be used for serum lithium drug monitoring; sodium heparin cannot be used for electrolyte sodium (Na+) panels.
Inversion Count: 8 to 10 gentle inversions.
Common Tests: STAT Electrolytes, STAT BMP/CMP, Cardiac Troponin I and T, Arterial/Venous Blood Gases (on ice), Plasma Renin, and Ammonia.
5. Lavender Top / Purple Top / Pink Top (Hematology & Immunohematology)
Additive: Dipotassium EDTA (K2-EDTA - spray-dried) or Tripotassium EDTA (K3-EDTA - liquid).
Mechanism of Action: EDTA is a powerful chelating agent that irreversibly binds divalent ionized calcium (Ca2+ / Factor IV), a cofactor required for nearly every step of the coagulation cascade. EDTA is the anticoagulant of choice for hematology because it preserves cellular morphology, prevents platelet aggregation/clumping, and maintains RBC size and shape without altering cell counts.
Pink Top Tube: Contains K2-EDTA with a specialized blood bank patient identification label. Used specifically for Immunohematology: Blood typing (ABO/Rh), Crossmatch, and Antibody Screening.
Inversion Count: 8 to 10 gentle inversions.
Common Tests: Complete Blood Count (CBC with automated 5-part differential), Hemoglobin and Hematocrit (H&H), Platelet Count, Reticulocyte Count, Erythrocyte Sedimentation Rate (ESR), and Hemoglobin A1c (HbA1c for diabetes management).
6. Gray Top (Glycolytic Inhibitor / Glucose)
Additives: Sodium Fluoride (antiglycolytic agent) combined with Potassium Oxalate (anticoagulant).
Mechanism of Action:
Sodium Fluoride: Inhibits the enzyme enolase in the glycolytic pathway. In unpreserved whole blood, red blood cells and leukocytes consume glucose at a rate of 5% to 10% (approximately 5–10 mg/dL) per hour at room temperature via in vitro glycolysis. Sodium fluoride halts glycolysis, preserving baseline glucose concentrations for up to 3 days (72 hours).
Potassium Oxalate: Precipitates calcium ions to prevent coagulation.
Inversion Count: 8 to 10 gentle inversions.
Common Tests: Fasting Blood Glucose (FBG), 2-Hour Postprandial Glucose, 3-Hour Oral Glucose Tolerance Tests (OGTT), Lactic Acid (requires gray tube placed immediately in ice slurry), and Legal Blood Alcohol (Ethanol) determinations.
7. Specialized Collection Tubes
Royal Blue Top: Contains either K2-EDTA (lavender stripe) or Clot Activator / No Additive (red stripe). Tubes are manufactured from trace-element-free glass/plastic (<0.01 µg/mL contaminants). Used for Trace Elements, Heavy Metals (Lead, Mercury, Arsenic, Copper, Zinc) , and Forensic Toxicology.
Yellow Top (Acid Citrate Dextrose - ACD Solution A or B): Preserves white blood cell viability and cellular antigens for DNA testing, HLA phenotyping (organ transplant compatibility) , and Paternity Evaluation.
Orange / Gray-Yellow Top (Rapid Serum Tube - RST): Contains a thrombin-based clot activator that achieves complete clotting within 5 minutes for STAT serum chemistry.
3. Comprehensive Order of Draw & Additive Reference Table
Order Stopper Color Additive Action / Mechanism Inversions Primary Department & Common Diagnostic Tests
1 Yellow / Bottles Sodium Polyanethol Sulfonate (SPS) or Nutrient Broth Anticoagulant; binds calcium; inactivates complement, phagocytes, and antibiotics. 8–10 Microbiology: Blood cultures for bacteremia, septicemia, endocarditis, and FUO.
2 Light Blue Buffered Sodium Citrate (3.2%) Anticoagulant; reversibly binds calcium. Requires strict 9:1 blood:anticoagulant ratio (±10%). 3–4 Coagulation: PT/INR, aPTT, Fibrinogen, D-Dimer, Thrombin Time, Factor Assays.
3 Red / Gold / Tiger (SST) Clot activator (Silica) ± Polyester Gel Barrier Activates clotting cascade; gel forms physical barrier between serum and packed RBCs. Clot 30–60 min. 5 (SST); 0 (Glass) Chemistry / Serology: CMP, BMP, Lipid Panel, Thyroid Panel, Hepatic Panel, HIV, RPR, HCG.
4 Green / Light Green (PST) Lithium Heparin or Sodium Heparin ± Gel Anticoagulant; inhibits thrombin and Factor Xa via antithrombin III. Yields uncoagulated plasma. 8–10 Chemistry (STAT): STAT Electrolytes, STAT BMP/CMP, Cardiac Troponin I/T, Ammonia (on ice).
5 Lavender / Purple / Pink K2-EDTA or K3-EDTA (Spray-dried / Liquid) Anticoagulant; irreversibly chelates calcium. Preserves cellular morphology and prevents platelet clumping. 8–10 Hematology: CBC, Differential, Platelets, ESR, HbA1c.; Blood Bank (Pink): ABO/Rh Type, Crossmatch.
6 Gray Sodium Fluoride + Potassium Oxalate Antiglycolytic agent (inhibits enolase) + anticoagulant (precipitates calcium). Preserves glucose 72h. 8–10 Chemistry: Fasting Glucose, Oral Glucose Tolerance Test (OGTT), Lactic Acid (on ice), Blood Alcohol.
-- Royal Blue K2-EDTA or Clot Activator (Trace-element free) Chemically cleaned to eliminate trace metal contamination. 8–10 (EDTA); 5 (Clot) Toxicology / Chemistry: Lead, Arsenic, Mercury, Copper, Zinc, Heavy Metal panels.
- 4. Specimen Processing, Centrifugation & Special Transport Conditions Serum vs. Plasma Composition
- ---------------------------
- WHOLE BLOOD (Clotted) ==[Centrifuge]==> SERUM (Liquid minus Fibrinogen/Clotting Factors) + CLOT
- WHOLE BLOOD (Anticoag.) ==[Centrifuge]==> PLASMA (Liquid with Fibrinogen/Clotting Factors) + BUFFY COAT + RBCs
- Serum vs. Plasma Distinction
Serum: The clear, pale-yellow liquid portion of blood obtained AFTER complete coagulation has taken place. Because blood has clotted, serum contains NO fibrinogen or clotting factors (they have been consumed in forming the fibrin clot). Serum is collected in non-additive (red) or clot activator (gold SST) tubes.
Plasma: The liquid portion of blood obtained from UNCLOTTED blood containing an anticoagulant (citrate, heparin, or EDTA). Plasma contains fibrinogen, prothrombin, and all active clotting factors , along with dissolved proteins, electrolytes, and nutrients.
Centrifugation Protocols
Clotting Verification: Serum tubes must clot completely for 30 to 60 minutes at room temperature before centrifugation. (Rapid serum tubes with thrombin clot in 5 minutes; orange tubes). Never centrifuge an incompletely clotted tube, as residual fibrin will polymerize post-spin, trapping serum and blocking laboratory analyzer pipettes.
Centrifuge Balancing: A centrifuge spinning at high speeds must be precisely balanced . Every tube placed in the centrifuge must be counterbalanced by a tube of identical size, volume, and weight positioned directly opposite (180°) across the rotor head. An unbalanced centrifuge causes violent vibration, rotor bearing damage, tube breakage, and aerosolization of infectious blood.
Speed and Duration: Centrifuge standard blood specimens at 1,000 to 2,000 g (Relative Centrifugal Force - RCF) for 10 to 15 minutes with the centrifuge lid locked hermetically.
The No Re-Spin Rule: Never re-centrifuge a Serum Separator Tube (SST) . Re-spinning causes the gel barrier to shift, forcing old, intracellular potassium, lactate dehydrogenase (LDH), and hemoglobin from hemolyzed packed red cells back into the separated serum, producing severe analytical errors.
Special Specimen Transport & Preservation Requirements
Handling Category Diagnostic Analytes Required Preservation Protocol & Clinical Rationale
Light-Sensitive (Photosensitive) Bilirubin (Neonatal & Adult) , Vitamin B12, Folate, Vitamin A, Vitamin B6, Carotene, Porphyrins. Protect from Light Immediately. Exposure to ambient fluorescent light or sunlight causes rapid photodegradation (bilirubin breaks down by up to 50% per hour). Collect in an amber-tinted collection tube or immediately wrap the tube completely in aluminum foil or place in a light-blocking transport bag.
Cold / Chilled Specimens Ammonia, Lactic Acid , Arterial Blood Gases (ABG), Gastrin, Glucagon, ACTH, Parathyroid Hormone (PTH), Renin. Immediate Crushed Ice & Water Slurry (0°C / 32°F). Chilling halts cellular metabolism, stops in vitro enzymatic degradation, and prevents red blood cells from consuming analytes or releasing intracellular ammonia. Crucial: Specimen must be placed in a wet slurry of crushed ice and water—never place tubes on dry ice or large ice cubes alone (which freezes and lyses erythrocytes).
Warmed Specimens (37°C) Cold Agglutinins, Cryoglobulins , Cryofibrinogen. Maintain at Body Temperature (37°C / 98.6°F). Cold agglutinins are auto-antibodies that bind to red blood cells at temperatures below 37°C, causing premature agglutination and false hemolytic anemia results. Tubes must be pre-warmed to 37°C prior to collection and transported in a 37°C portable heating block or water bath.